8 October 2019
It’s time for the private health industry to grow up and tackle its problems itself, instead of deflecting the blame.
6 August 2019
Health insurance costs are rising and the cost of prostheses such as hip replacements are partly to blame. But there is a way to rein in costs – and give patients more choice and better devices.
16 July 2019
Policy makers cannot develop good policies on private health insurance unless they are clear about what the industry is about and how it works alongside Medicare. Grattan’s new working paper is designed to start that conversation.
11 July 2019
Australia’s policy on private health insurance is a muddle. Our political leaders need to confront a fundamental question: how does private health insurance fit with public health insurance (Medicare)?
5 July 2019
Primary care was barely discussed in the 2019 federal election campaign. Reform is needed, but it’s difficult. Here’s why.
11 June 2019
Victoria’s ‘Smile Squad’ for public schools is a welcome step towards a Medicare-style universal dental care scheme for Australia.
4 June 2019
Grattan’s Transport Program Director Marion Terrill and Visiting Health Fellow Hal Swerissen look at the policy challenges facing Infrastructure Shadow Minister Catherine King, NDIS Shadow Minister Bill Shorten, Health Shadow Minister Chris Bowen, and Ageing and Seniors and Women Shadow Minister Julie Collins.
29 May 2019
Grattan’s Transport Program Director Marion Terrill and Visiting Health Fellow Hal Swerissen look at the policy challenges facing Infrastructure Minister Michael McCormack, NDIS Minister Stuart Robert, and Aged Care Minister Richard Colbeck.
19 May 2019
High on Minister Greg Hunt’s agenda will be the unmentionables – all the things the Coalition avoided talking about in the campaign but which nevertheless loom as challenges in health policy.
7 May 2019
Labor is front-footing health, fitting neatly into its overall campaign meme of addressing cost of living pressures. The Liberals are using re-announcements of previous commitments and an innovative personalisation of the benefit of new drugs to present their health credentials.